Contact this trialFirst, we need to learn more about you.
Enzyme
Chemotherapy for Acute Myeloid Leukemia in Young Patients with Down Syndrome
Recruiting2 awardsPhase 3
Winston-Salem, North Carolina
This trial is studying how effective response-based chemotherapy is in treating younger patients with Down syndrome who have acute myeloid leukemia or myelodysplastic syndrome.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.